# Renibus Therapeutics, Inc. — Form D

Renibus Therapeutics, Inc. of SOUTHLAKE, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-29. The offering totals $20.0M, of which $14.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-07-29
- Form: D
- Accession: 0001667699-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $14.9M
- Remaining: $5.1M
- Investors: 17
- Date of first sale: 2022-07-15
- Revenue range: Decline to Disclose
- SEC file number: 021-454246

## Issuer

- Name: Renibus Therapeutics, Inc.
- CIK: 0001667699
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 181 GRAND AVE., SUITE 225, SOUTHLAKE, TX, 76092
- Phone: 386-527-1071

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| Jamie Jeffrey Donadio | Executive Officer | Southlake, TX |
| Bhupinder Jeffrey Singh | Director | Southlake, TX |
| Bhupinder Jeffrey Singh | Executive Officer | Southlake, TX |
| Carlos Guillem | Director | Southlake, TX |
| Carlos Guillem | Executive Officer | Southlake, TX |
| D. Jeffrey Keyser | Director | Southlake, TX |
| D. Jeffrey Keyser | Executive Officer | Southlake, TX |
| Henrik Jeffrey Rasmussen | Director | Southlake, TX |
| Dale Jones | Director | Argyle, TX |
| Frank Jeffrey Stonebanks | Director | Southlake, TX |
| Frank Jeffrey Stonebanks | Executive Officer | Southlake, TX |
| Alvaro Guillem | Director | Southlake, TX |
| Alvaro Guillem | Executive Officer | Southlake, TX |
| Jennifer D Rasmussen | Director | Lantana, TX |
| Harpreet Kaur | Director | Lantana, TX |
| Harpreet Kaur | Executive Officer | Lantana, TX |
| Nels D Bergmark | Executive Officer | Lantana, TX |
| Jocelyn D Keyser | Director | Lantana, TX |

## Other filings by this issuer (13)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-07-17](https://search.stillhousedata.com/formd/0001667699-25-000002) | D/A | $110.9M | $110.9M |
| [2023-09-18](https://search.stillhousedata.com/formd/0001567619-23-007234) | D/A | $103.4M | $95.9M |
| [2023-06-09](https://search.stillhousedata.com/formd/0001567619-23-006327) | D | $73.4M | $63.8M |
| [2022-08-22](https://search.stillhousedata.com/formd/0001667699-22-000003) | D/A | $25.0M | $23.4M |
| [2022-02-18](https://search.stillhousedata.com/formd/0001667699-22-000001) | D/A | $34.6M | $34.6M |
| [2020-07-15](https://search.stillhousedata.com/formd/0001667699-20-000001) | D/A | $35.0M | $19.8M |
| [2019-11-19](https://search.stillhousedata.com/formd/0001667699-19-000003) | D/A | $35.0M | $16.3M |
| [2019-09-23](https://search.stillhousedata.com/formd/0001667699-19-000001) | D | $3.4M | $3.4M |
| [2016-05-02](https://search.stillhousedata.com/formd/0001667699-16-000005) | D/A | $12.5M | $10.9M |
| [2016-04-12](https://search.stillhousedata.com/formd/0001667699-16-000004) | D/A | $12.5M | $10.2M |
| [2016-03-23](https://search.stillhousedata.com/formd/0001667699-16-000003) | D/A | $12.5M | $8.3M |
| [2016-02-24](https://search.stillhousedata.com/formd/0001667699-16-000002) | D | $10.0M | $2.9M |
| [2016-02-23](https://search.stillhousedata.com/formd/0001667699-16-000001) | D | $300K | $300K |

## More

- [CIK 1667699 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1667699&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001667699-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.